Dental Replacements Training Academy
Education · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1110 W Shore Dr Ste E, Richardson, Texas...Phone Number
(214) 914-1535Website
www.dentalreplacements.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Dental Replacements Training Academy
Dental Replacements Serves the Dallas Ft. Worth Metroplex with a commitment to Professionalism. We quickly place all types of permanent and temporary Dental Staff.Explore more
Dental Replacements Training Academy Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dental Replacements Training Academy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Dental Replacements Training Academy had a recent Job posting/layoffs
Earning: See what the market has to say on Dental Replacements Training Academy recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Dental Replacements Training Academy, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Dental Replacements Training Academy has new funding data
Check if Dental Replacements Training Academy has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Dental Replacements Training Academy launches new products
Website visits: Recent activity has been detected on your website
Check out if Dental Replacements Training Academy is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Dental Replacements Training Academy
Recommended Actions
Find VP level buyers at Dental Replacements Training Academy
Find 3 more new buyers
Compare Similar Companies to Dental Replacements Training Academy
Compare insights from companies similar to Dental Replacements Training Academy, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dental Replacements Training Academy financials insights
Gather financial insights about Dental Replacements Training Academy, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$11K
Dental Replacements Training Academy Tech Stack
A closer look at the technologies used by Dental Replacements Training Academy
Dental Replacements Training Academy News & Media
Advicenne Receives Health Canada Clearance to Extend its Pivotal Phase III Trial of ADV7103 in Canada
NÎMES, France--(BUSINESS WIRE)--Regulatory News: Advicenne (Paris:ADVIC), a specialty pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announced today that it has received a No Objection Letter to extend its ARENA-2 pivotal Phase III trial for the treatment of distal Renal Tubular Acidosis (dRTA) in Canada from Health Canada’s Office of Clinical Trial. “After clearance obtained in September from theAdvicenne Reports First-Half 2018 Results and Confirms Outlook for 2018
NÎMES, France--(BUSINESS WIRE)--Regulatory News: Advicenne (Paris:ADVIC), a French company specializing in the development of therapeutic products for adults and children for the treatment of orphan renal and neurological diseases, today published its first-half financial results as of June 30, 2018 and confirms its operating outlook for 2018. First-Half 2018 and Subsequent Key Achievements On January 5, 2018, Advicenne exercised approximately 72% of the over-allotment option relating to its inAdvicenne receives approval for Marketing Authorization for ADV6209 in Pediatric Moderate Sedation
NÎMES, France--(BUSINESS WIRE)--Regulatory News: Advicenne (Paris:ADVIC) (Euronext: ADVIC), a specialty pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announced today that the company has received from European National regulatory authorities the marketing authorization approval for ADV6209 in pediatric moderate sedation, after completing a decentralized procedure. OZALIN® (ADV6209’s brand name) iCORRECTING and REPLACING: Advicenne to Host a Conference Call on September 12, 2018 at 6 PM to Comment Its Recent Developments
NÎMES, France--(BUSINESS WIRE)--Regulatory News: This replaces the announcement made at 06:45 pm CEST on 09/11/2018 due to the following corrections: correction in the title. Advicenne to Host a Conference Call on September 12, 2018 at 6 PM to Comment Its Recent Developments Advicenne (Euronext: ADVIC), a specialty pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, today announced that the management
Read more news
Top Education Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dental Replacements Training Academy
Sign Up For FreeTo access detailed company insights
Dental Replacements Serves the Dallas Ft. Worth Metroplex with a commitment to Professionalism. We quickly place all types of permanent and temporary Dental Staff.... Read More
